SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches an Investigation into
Possible Breaches of Fiduciary Duty by the Board of Directors of Anthera
Pharmaceuticals, Inc. in Connection with Executive Compensation
NEW YORK -- February 13, 2013
Levi & Korsinsky, LLP is investigating Anthera Pharmaceuticals, Inc.
(NasdaqGM: ANTH), and its Board of Directors, in connection with the
compensation provided to certain of its executive officers.
To get more information, click here:
http://zlk.9nl.com/anthera-pharmaceuticals-anth/. There is no cost or
obligation to you.
If you own common stock in Anthera Pharmaceuticals, Inc. and wish to obtain
additional information, please contact Eduard Korsinsky, Esq. either via email
at firstname.lastname@example.org or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or
Levi & Korsinsky is a national firm with offices in New York, New Jersey, and
Washington D.C. The firm has extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors throughout the
nation in securities and shareholder lawsuits. The attorneys at Levi &
Korsinsky have been appointed by numerous courts throughout the country to
serve as lead counsel on behalf of shareholders in major securities lawsuits
and have successfully recovered multimillion-dollar damages awards on behalf
of investors. For more information, please feel free to contact any of the
attorneys listed below. Attorney advertising. Prior results do not guarantee
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq., 212-363-7500
Toll Free: 877-363-5972
Press spacebar to pause and continue. Press esc to stop.